HomeCapmatinib

Capmatinib

Route: Oral

Check Capmatinib Interactions →
7 interactions on record

Capmatinib has 7 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Cyp3a Inducers, Rosuvastatin, Rosuvastatin Calcium. Patients taking Capmatinib should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
7
Major
3
Moderate
4

Major (3)

  • Capmatinib + Cyp3a InducersCoadministration with strong CYP3A inducers decreased capmatinib exposure, which may decrease TABRECTA anti-tumor activi
  • Capmatinib + RosuvastatinCapmatinib increased rosuvastatin exposure more than 2.1-fold, increasing the risk of myopathy and rhabdomyolysis. Do no
  • Capmatinib + Rosuvastatin CalciumCapmatinib increases rosuvastatin exposure more than 2.1-fold, increasing risk of myopathy and rhabdomyolysis. Do not ex

Moderate (4)

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.